Skip to main content
梓橦宫 logo

梓橦宫 — Investor Relations & Filings

Ticker · 920566 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 625 across all filing types
Latest filing 2022-10-25 Major Shareholding Noti…
Country CN China
Listing Beijing Stock Exchange 920566

About 梓橦宫

http://www.zitonggong.com/

Zitonggong specializes in the research, development, and production of specialized therapeutic agents. Established with a heritage dating back to 1780, the company holds a recognized heritage brand designation. Its primary product portfolio centers on neurological and cerebrovascular health, featuring Oxiracetam in various dosage forms for treating cognitive dysfunction and brain injuries. The company also develops treatments for digestive health, including Compound Aloe Capsules, and produces artificial Oriental Bezoar. Operations are centered on integrating traditional medicinal knowledge with modern chemical synthesis and manufacturing standards. The company maintains a focus on clinical efficacy and technological advancement in the fields of neurology and gastroenterology.

Recent filings

Filing Released Lang Actions
实际控制人的一致行动人及持股百分之五以上股东减持股份计划公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement regarding a planned reduction in shareholdings by certain shareholders holding more than 5% of the company's shares. It details the shareholders involved, the number and percentage of shares to be reduced, the methods and timing of the reduction, and compliance with relevant securities regulations. There is no financial statement, earnings data, or management discussion of results. The document is not a report but an announcement about shareholding changes and reduction plans. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2022-10-25 Chinese
关于取得实用新型专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the acquisition of a utility model patent certificate. It includes details about the patent, its inventors, application and authorization dates, and the impact on the company. There is no financial data, no mention of financial results, no regulatory filings related to financial performance, no shareholder voting results, no management changes, no capital or financing updates, and no legal proceedings. The document is a regulatory announcement about intellectual property rights, which does not fit into financial report categories. It is a general regulatory announcement about company developments, best classified under Regulatory Filings (RNS). The document length is short and it is not a report publication announcement or certification. Therefore, the appropriate classification is Regulatory Filings (RNS) with high confidence.
2022-10-16 Chinese
上海天璇律师事务所关于四川梓橦宫药业股份有限公司2022年第三次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the procedural legality of a company's 2022 third extraordinary general meeting of shareholders. It details the convening, attendance, voting procedures, and results of the shareholders' meeting, confirming compliance with relevant laws and company articles. It does not contain financial statements, earnings data, or management discussion, nor is it a report publication announcement. The document is focused on the validation of the shareholders' meeting process and voting results, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 3228 characters, which is consistent with a detailed legal opinion on voting results rather than a full annual or interim report.
2022-10-12 Chinese
2022年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 2022 third extraordinary general meeting of shareholders of Sichuan Zitonggong Pharmaceutical Co., Ltd. It details the meeting date, attendance, agenda items, voting results, and legal opinions confirming the validity of the meeting and resolutions. There is no financial data or report content, but rather a summary of voting outcomes and procedural compliance. This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA). The document length is short and focused on voting results, not a full report or presentation.
2022-10-12 Chinese
关于2022年第三次临时股东大会延期的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the postponement of the 2022 third extraordinary general meeting of shareholders (临时股东大会延期的公告). It details the original and new dates for the meeting and voting procedures, but does not contain any financial data, management discussion, or report content. The document is short (1240 characters) and serves as a notification about the change in meeting schedule. Therefore, it is not a report itself but an announcement related to shareholder meeting logistics. This fits the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-09-19 Chinese
关于取得实用新型专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (544 characters) about the company obtaining a utility model patent certificate. It includes details about the patent and its impact on the company. There is no financial data, no mention of financial results, no regulatory filings, or meeting materials. It is not a report or a financial filing but a general corporate announcement about intellectual property. This type of announcement does not fit into any specific financial report category and is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous corporate announcements that do not fit other categories.
2022-09-04 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.